NLM Digital Collections

Search

Start Over Subjects Opiate Substitution Treatment ✖Remove constraint Subjects: Opiate Substitution Treatment

1. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States

3. Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary

Author(s):
Tice, Jeffrey A., author
Whittington, Melanie D., author
Fluetsch, Noemi, author
Zapata, Lorenzo Villa, author
Mendola, Nicolas D., author
Chapman, Rick M., author
Campbell, Jonathan D., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 11, 2020
Subject(s):
Behavior Therapy
Digital Technology
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
United States

4. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Treatment Outcome
Humans
United States

5. Federal legislation to address the opioid crisis: Medicaid provisions in the SUPPORT Act

Author(s):
Musumeci, MaryBeth, author
Tolbert, Jennifer, author
Publication:
San Francisco, CA : Henry J. Kaiser Family Foundation, October 2018
Subject(s):
Opioid-Related Disorders -- prevention & control
Opioid-Related Disorders -- rehabilitation
Opioid-Related Disorders -- therapy
Rehabilitation -- legislation & jurisprudence
Substance-Related Disorders -- prevention & control
Substance-Related Disorders -- rehabilitation
Substance-Related Disorders -- therapy
Analgesics, Opioid -- therapeutic use
Federal Government
Insurance, Health, Reimbursement
Medicaid
Opiate Substitution Treatment
Pain Management
Prescription Drug Monitoring Programs
Humans
United States

6. Financing community health workers in transitions clinics

Author(s):
Hogan, Laura, author
Macdonald Mendez, Tracy, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, November 2018
Subject(s):
Ambulatory Care Facilities -- economics
Community Health Services -- economics
Community Health Workers -- economics
Primary Health Care -- economics
Prisoners
Transitional Care -- economics
Case Management
Health Services Needs and Demand
Managed Care Programs
Mental Health Services
Opiate Substitution Treatment
Patient-Centered Care
Vulnerable Populations
Humans
California
United States

7. Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic

Publication:
Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, August 2022
Subject(s):
Controlled Substances -- supply & distribution
COVID-19
Electronic Prescribing
Federal Government
Health Services Accessibility
Opiate Substitution Treatment
State Government
United States

8. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
Subject(s):
Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

9. How community health centers are addressing the opioid epidemic: case study

Author(s):
Hayes, Robert M., author
Squitieri, Joseph, author
Publication:
New York, NY : Milbank Memorial Fund, April 2019
Subject(s):
Child of Impaired Parents
Community Health Centers
Community Health Services
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Adolescent
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Child
Community Mental Health Services
Drug Overdose -- prevention & control
Humans
United States

10. Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic

Author(s):
Au-Yeung, Caroline M., author
Blewett, Lynn A., author
Winkelman, Tyler N.A., author
Publication:
New York, NY : Milbank Memorial Fund, October 2021
Subject(s):
Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
COVID-19
Health Policy
Methadone -- therapeutic use
Naltrexone -- therapeutic use
United States